|
YWHAE expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.839600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.669200E-01 |
| Normal-vs-Stage2 |
5.933800E-01 |
| Normal-vs-Stage3 |
6.836400E-03 |
| Normal-vs-Stage4 |
4.876000E-03 |
| Stage1-vs-Stage2 |
5.247700E-02 |
| Stage1-vs-Stage3 |
5.886200E-02 |
| Stage1-vs-Stage4 |
4.786300E-02 |
| Stage2-vs-Stage3 |
1.061710E-03 |
| Stage2-vs-Stage4 |
8.789900E-04 |
| Stage3-vs-Stage4 |
4.917600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.822600E-03 |
| Normal-vs-AfricanAmerican |
9.249000E-01 |
| Normal-vs-Asian |
1.868240E-01 |
| Caucasian-vs-AfricanAmerican |
1.303830E-01 |
| Caucasian-vs-Asian |
3.807200E-01 |
| AfricanAmerican-vs-Asian |
3.411800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.229700E-02 |
| Normal-vs-Female |
1.151770E-01 |
| Male-vs-Female |
4.242400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.680200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.123900E-02 |
| Normal-vs-Age(61-80Yrs) |
3.243700E-02 |
| Normal-vs-Age(81-100Yrs) |
3.831700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.643350E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.483160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.408600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.253800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.300200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.272800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.295800E-02 |
| Classical-VS-Follicular |
3.422400E-03 |
| Classical-VS-Other |
7.214000E-01 |
| Classical-VS-Normal |
4.891700E-02 |
| Tall-VS-Follicular |
1.152980E-04 |
| Tall-VS-Other |
1.297420E-01 |
| Tall-VS-Normal |
2.041400E-03 |
| Follicular-VS-Other |
5.131800E-01 |
| Follicular-VS-Normal |
5.495800E-01 |
| Other-VS-Normal |
6.582400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.299600E-01 |
| Normal-vs-N1 |
3.461000E-03 |
| N0-vs-N1 |
2.762100E-02 |
|
|
